TRUSTPOLITICS
M

Member

Speaking in the House of Commons on 11 July 2025

Debate

Rare Cancers Bill

Contribution

(5A) In subsection (5)(da) ‘relevant clinical trials’ means clinical trials in connection with the research and development of orphan medicinal products for the diagnosis, prevention or treatment of cancers that in the opinion of NHS England are rare cancers”.
← Previous speaker
In this debate
Next speaker →
In this debate

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.

UK Parliament — Rare Cancers Bill | TrustPolitics